Become a global leader in contrast agents
Established in 1997, Zhejiang Starry Pharmaceutical Co., Ltd. is a high-tech enterprise specialized in research and development, production and sales of X-CT nonionic iodine contrast agent series and quinolone series bulk drugs and intermediates. It is currently the production base of diagnostic bulk drugs in China. The company was listed on the Shanghai Stock Exchange on March 9, 2016 (Stock Code: 603520).
About
1997
Year
Company establishment
603520
Code
Shanghai Stock Exchange
1800
individual
Excellent staff
3
species
R&D platform
For more details, see Starry Pharmaceutical
A global professional contrast agent high-tech enterprise, Starry Pharm has a number of production bases and sales companies both at home and abroad, mainly including Jiangxi Starry, Shanghai Starry, Haishen Pharmaceutical and Irish IMAX.
Corporate culture
seek perfection in a down-to-earth manner
MORE
Strategic achievements of the company
Using new technology for sustainable innovation of human health
Product
News
Research
Responsibility
Wap
Copyright © 2019 Zhejiang Starry Pharmaceutical Co., Ltd. All Rights Reserved. 浙ICP备18046522号